ArticleBiomedical chromatography : BMC2026
Identification of Anti-Inflammatory Active Components in Morinda officinalis via Spectroscopic Effect Relationship Analysis and NF-κB Pathway Inhibition.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Morindae Officinalis Radix (MOR), the dried root of Morinda officinalis How, contains abundant saccharides and is used clinically after different processing procedures. However, the anti-inflammatory material basis of MOR and the chemical consequences of Lycium barbarum processing remain insufficiently defined. In this study, high-performance liquid chromatography coupled with evaporative light scattering detection (HPLC-ELSD) was developed for fingerprint analysis of 15 batches of raw MOR and the corresponding L. barbarum-processed MOR (LB-MOR). Seventeen common peaks were resolved, and 11 saccharides were assigned by comparison with reference standards. Anti-inflammatory activity was evaluated in LPS-stimulated RAW 264.7 macrophages by quantifying nitric oxide (NO), TNF-α, IL-1β, and IL-6. Grey relational analysis and partial least squares regression linked the HPLC fingerprints with bioactivity and identified glucose, sucrose, kestose, and nystose as the principal activity-associated saccharides. Subsequent validation showed that these saccharides inhibited inflammatory mediator release, with kestose and nystose showing the strongest effects. Western blotting further indicated that kestose and nystose restored IκBα expression and decreased COX-2 expression and the p-p65/p65 ratio, consistent with suppression of sustained NF-κB signaling. This separation-based fingerprint and spectrum-effect workflow identify anti-inflammatory oligosaccharides in MOR and provides candidate quality markers for raw and processed MOR products.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.